−0.704 EUR
−8.33 M EUR
336.00 K EUR
3.00 M
About 4SC AG
Sector
Industry
CEO
Jason Loveridge
Website
Headquarters
Planegg-Martinsried
Founded
2000
ISIN
DE000A3E5C40
FIGI
BBG000MXBT60
4SC AG is a clinical-stage biopharmaceutical company, which engages in the development of small molecule drugs that target key indications in cancer. Its product pipeline includes resminostat and domatinostat. The company was founded by Stefan Busemann, Ulrich Dauer, Klaus-Peter Gulden, and Daniel Vitt in 1997 and is headquartered in Planegg-Martinsried, Germany.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange 4SC AG stocks are traded under the ticker VSC.
Yes, you can track 4SC AG financials in yearly and quarterly reports right on TradingView.
VSC net income for the last half-year is −3.30 M EUR, while the previous report showed −4.38 M EUR of net income which accounts for 24.65% change. Track more 4SC AG financial stats to get the full picture.
No, VSC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 19, 2025, the company has 15 employees. See our rating of the largest employees — is 4SC AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4SC AG EBITDA is −7.06 M EUR, and current EBITDA margin is −2.30 K%. See more stats in 4SC AG financial statements.
Like other stocks, VSC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4SC AG stock right from TradingView charts — choose your broker and connect to your account.